REGISTERED NUMBER: 06267170

FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2025

FOR

DENOVO HEALTHCARE LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

Chartered Accountants' Report

8

DIRECTORS:

Mr M A G Gibson

Mr N J Talbot

Mr R T G Gibson

REGISTERED OFFICE:

6A Wedmore Road

Cheddar

Somerset

BS27 3EB

REGISTERED NUMBER:

06267170

ACCOUNTANTS:

Lowson Ward

Chartered Accountants

292 Wake Green Road

Birmingham

B13 9QP

FIXED ASSETS

Tangible assets

3

18,216

20,321

CURRENT ASSETS

Stocks

122,252

144,914

Debtors

4

463,897

454,300

Cash at bank

127,913

129,682

714,062

728,896

CREDITORS

Amounts falling due within one year

5

(485,317

)

(513,209

)

NET CURRENT ASSETS

228,745

215,687

TOTAL ASSETS LESS CURRENT LIABILITIES

246,961

236,008

CREDITORS

Amounts falling due after more than one year

6

(10,417

)

(35,417

)

PROVISIONS FOR LIABILITIES

7

(4,550

)

(5,080

)

NET ASSETS

231,994

195,511

CAPITAL AND RESERVES

Called up share capital

60

60

Share premium

8

61,939

61,939

Capital redemption reserve

8

(138,460

)

(138,460

)

Retained earnings

8

308,455

271,972

SHAREHOLDERS' FUNDS

9

231,994

195,511

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 August 2026 and were signed on its behalf by:

Mr N J Talbot - Director

1.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Equipment

-

33% on reducing balance

Premises improvements

-

straight line over lease term

All fixed assets are initially recorded at cost.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Financial instruments

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

2.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 12 (2024 - 12 ) .

3.	TANGIBLE FIXED ASSETS

Premises

Equipment

improvements

Totals

£

£

£

COST

At 1 December 2024

86,978

50,280

137,258

Additions

4,351

1,180

5,531

At 30 November 2025

91,329

51,460

142,789

DEPRECIATION

At 1 December 2024

68,840

48,097

116,937

Charge for year

6,536

1,100

7,636

At 30 November 2025

75,376

49,197

124,573

NET BOOK VALUE

At 30 November 2025

15,953

2,263

18,216

At 30 November 2024

18,138

2,183

20,321

4.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30/11/25

30/11/24

£

£

Trade debtors

389,834

384,303

Other debtors

60,000

60,000

Prepayments

14,063

9,997

463,897

454,300

5.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30/11/25

30/11/24

£

£

Trade creditors

318,163

370,628

Corporation tax

65,316

52,405

PAYE and NIC

8,591

5,182

VAT

73,570

71,142

Other creditors

7,430

4,191

Pension

1,051

1,013

Directors' current accounts

2,302

3,354

Accruals and deferred income

8,894

5,294

485,317

513,209

6.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

30/11/25

30/11/24

£

£

Bank loans - 1-2 years

10,417

25,000

Other loans - 2-5 years

-

10,417

10,417

35,417

7.	PROVISIONS FOR LIABILITIES

30/11/25

30/11/24

£

£

Deferred tax

Accelerated capital allowances

4,550

5,080

Deferred

tax

£

Balance at 1 December 2024

5,080

Provided during year

(530

)

Balance at 30 November 2025

4,550

8.

RESERVES

Capital

Retained

Share

redemption

earnings

premium

reserve

Totals

£

£

£

£

At 1 December 2024

271,972

61,939

(138,460

)

195,451

Profit for the year

221,841

-

-

221,841

Dividends

(185,358

)

-

-

(185,358

)

At 30 November 2025

308,455

61,939

(138,460

)

231,934

9.	RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS

30/11/25

30/11/24

£

£

Profit for the financial year

221,841

193,518

Dividends

(185,358

)

(178,000

)

36,483

15,518

Opening shareholders' funds

-

179,993

Net addition to shareholders' funds

36,483

195,511

Opening shareholders' funds

195,511

-

Closing shareholders' funds

231,994

195,511

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Denovo Healthcare Ltd for the year ended 30 November 2025 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Denovo Healthcare Ltd, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Denovo Healthcare Ltd and state those matters that we have agreed to state to the Board of Directors of Denovo Healthcare Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Denovo Healthcare Ltd and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Denovo Healthcare Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Denovo Healthcare Ltd. You consider that Denovo Healthcare Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Denovo Healthcare Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Lowson Ward

Chartered Accountants

292 Wake Green Road

Birmingham

B13 9QP

12 August 2026